BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27095514)

  • 1. Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
    Jadhavar PS; Dhameliya TM; Vaja MD; Kumar D; Sridevi JP; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2663-9. PubMed ID: 27095514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation.
    Jadhavar PS; Patel KI; Dhameliya TM; Saha N; Vaja MD; Krishna VS; Sriram D; Chakraborti AK
    Bioorg Chem; 2020 Jun; 99():103774. PubMed ID: 32224336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
    Dhameliya TM; Tiwari R; Banerjee A; Pancholia S; Sriram D; Panda D; Chakraborti AK
    Eur J Med Chem; 2018 Jul; 155():364-380. PubMed ID: 29902722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
    Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
    Asquith CRM; Fleck N; Torrice CD; Crona DJ; Grundner C; Zuercher WJ
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2695-2699. PubMed ID: 31378571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
    Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
    Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
    Xu Z; Zhang S; Song X; Qiang M; Lv Z
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
    Penta A; Franzblau S; Wan B; Murugesan S
    Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
    Hwang JM; Oh T; Kaneko T; Upton AM; Franzblau SG; Ma Z; Cho SN; Kim P
    J Nat Prod; 2013 Mar; 76(3):354-67. PubMed ID: 23360475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents.
    Odingo J; O'Malley T; Kesicki EA; Alling T; Bailey MA; Early J; Ollinger J; Dalai S; Kumar N; Singh RV; Hipskind PA; Cramer JW; Ioerger T; Sacchettini J; Vickers R; Parish T
    Bioorg Med Chem; 2014 Dec; 22(24):6965-79. PubMed ID: 25456390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents.
    Singh N; Pandey SK; Anand N; Dwivedi R; Singh S; Sinha SK; Chaturvedi V; Jaiswal N; Srivastava AK; Shah P; Siddiqui MI; Tripathi RP
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4404-8. PubMed ID: 21737274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
    Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
    Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
    Modi P; Patel S; Chhabria M
    Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
    Fan YL; Wu JB; Ke X; Huang ZP
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Aminoaryl-3,5-diaryl pyrazines: Synthesis, biological evaluation against Mycobacterium tuberculosis and docking studies.
    Gangarapu NR; Ranganatham A; Reddy EK; Yellappa S; Chandrasekhar KB
    Arch Pharm (Weinheim); 2020 Jul; 353(7):e1900368. PubMed ID: 32399980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.